Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Ester Alvino"'
Autor:
Lauretta Levati, Claudio Tabolacci, Antonio Facchiano, Francesco Facchiano, Ester Alvino, Gian Carlo Antonini Cappellini, Enrico Scala, Laura Bonmassar, Simona Caporali, Pedro Miguel Lacal, Antonella Bresin, Federica De Galitiis, Giandomenico Russo, Stefania D’Atri
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-19 (2024)
Abstract Background Circulating cytokines can represent non-invasive biomarkers to improve prediction of clinical outcomes of cancer patients. Here, plasma levels of IL-8, CCL4, osteopontin, LIF and BDNF were determined at baseline (T0), after 2 mont
Externí odkaz:
https://doaj.org/article/a0bdc7a211eb48ef9b02d1cc5e1b8897
Autor:
Simona Caporali, Adriana Amaro, Lauretta Levati, Ester Alvino, Pedro Miguel Lacal, Simona Mastroeni, Federica Ruffini, Laura Bonmassar, Gian Carlo Antonini Cappellini, Nadia Felli, Alessandra Carè, Ulrich Pfeffer, Stefania D’Atri
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-24 (2019)
Abstract Background Development of resistance to inhibitors of BRAF (BRAFi) and MEK (MEKi) remains a great challenge for targeted therapy in patients with BRAF-mutant melanoma. Here, we explored the role of miRNAs in melanoma acquired resistance to B
Externí odkaz:
https://doaj.org/article/ad44b34751c2441eb4d91f50e0307725
Autor:
Marco Galasso, Carl Morrison, Linda Minotti, Fabio Corrà, Carlotta Zerbinati, Chiara Agnoletto, Federica Baldassari, Matteo Fassan, Armando Bartolazzi, Andrea Vecchione, Gerard J. Nuovo, Gianpiero Di Leva, Stefania D’Atri, Ester Alvino, Maurizio Previati, Brian J. Nickoloff, Carlo M. Croce, Stefano Volinia
Publikováno v:
Molecular Cancer, Vol 17, Iss 1, Pp 1-6 (2018)
Abstract Cutaneous melanoma (CM) is a malignancy with increasing occurrence. Its microRNA repertoire has been defined in a number studies, leading to candidates for biological and clinical relevance: miR-200a/b/c, miR-203, miR-205, miR-204, miR-211,
Externí odkaz:
https://doaj.org/article/276b897ea58a4f74b9ffb33c4fd15ed6
Autor:
Nadia Felli, Federica Felicetti, Anna Maria Lustri, M Cristina Errico, Lisabianca Bottero, Alessio Cannistraci, Alessandra De Feo, Marina Petrini, Francesca Pedini, Mauro Biffoni, Ester Alvino, Massimo Negrini, Manuela Ferracin, Gianfranco Mattia, Alessandra Carè
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56824 (2013)
The abnormal expression of several microRNAs has a causal role in tumorigenesis with either antineoplastic or oncogenic functions. Here we demonstrated that miR-126 and miR-126* play a tumor suppressor role in human melanoma through the direct or ind
Externí odkaz:
https://doaj.org/article/7263ac5345e84f3485b63a1e455ef846
Autor:
Lauretta Levati, Cristian Bassi, Simona Mastroeni, Laura Lupini, Gian Carlo Antonini Cappellini, Laura Bonmassar, Ester Alvino, Simona Caporali, Pedro Miguel Lacal, Maria Grazia Narducci, Ivan Molineris, Federica De Galitiis, Massimo Negrini, Giandomenico Russo, Stefania D’Atri
Publikováno v:
Cancers; Volume 14; Issue 15; Pages: 3706
Despite the significant improvements in advanced melanoma therapy, there is still a pressing need for biomarkers that can predict patient response and prognosis, and therefore support rational treatment decisions. Here, we investigated whether circul
Autor:
Ester Alvino, Federica Ruffini, Gian Carlo Antonini Cappellini, Laura Bonmassar, Lauretta Levati, Stefania D'Atri, Pedro Miguel Lacal, Alessandro Scoppola, Simona Mastroeni, Paolo Marchetti, Simona Caporali
Publikováno v:
Oncotarget. 8:113472-113493
The pituitary tumor transforming gene 1 (PTTG1) is implicated in tumor growth, metastasis and drug resistance. Here, we investigated the involvement of PTTG1 in melanoma cell proliferation, invasiveness and response to the BRAF inhibitor (BRAFi) dabr
Autor:
Gian Carlo Antonini Cappellini, Lauretta Levati, Ester Alvino, Alessandra Carè, Ulrich Pfeffer, Pedro Miguel Lacal, Simona Caporali, Stefania D'Atri, Federica Ruffini, Adriana Amaro, Simona Mastroeni, Laura Bonmassar, Nadia Felli
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-24 (2019)
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-24 (2019)
Background Development of resistance to inhibitors of BRAF (BRAFi) and MEK (MEKi) remains a great challenge for targeted therapy in patients with BRAF-mutant melanoma. Here, we explored the role of miRNAs in melanoma acquired resistance to BRAFi. Met
Autor:
Ester Alvino, Carlotta Zerbinati, Marco Galasso, Armando Bartolazzi, Gerard J. Nuovo, Maurizio Previati, Linda Minotti, Chiara Agnoletto, Carl Morrison, Gianpiero Di Leva, Carlo M. Croce, Federica Baldassari, Stefano Volinia, Fabio Corrà, Brian J. Nickoloff, Matteo Fassan, Stefania D'Atri, Andrea Vecchione
Publikováno v:
Molecular Cancer, Vol 17, Iss 1, Pp 1-6 (2018)
Molecular Cancer
Molecular Cancer
Cutaneous melanoma (CM) is a malignancy with increasing occurrence. Its microRNA repertoire has been defined in a number studies, leading to candidates for biological and clinical relevance: miR-200a/b/c, miR-203, miR-205, miR-204, miR-211, miR-23b a
Autor:
Simona, Caporali, Ester, Alvino, Pedro Miguel, Lacal, Federica, Ruffini, Lauretta, Levati, Laura, Bonmassar, Alessandro, Scoppola, Paolo, Marchetti, Simona, Mastroeni, Gian Carlo, Antonini Cappellini, Stefania, D'Atri
Publikováno v:
Oncotarget
The pituitary tumor transforming gene 1 (PTTG1) is implicated in tumor growth, metastasis and drug resistance. Here, we investigated the involvement of PTTG1 in melanoma cell proliferation, invasiveness and response to the BRAF inhibitor (BRAFi) dabr
Autor:
Josef Jiricny, Cristina Fortes, Francesca Passarelli, Simona Caporali, Elda Cannavo, Alessandro Scoppola, Simona Mastroeni, Stefania D'Atri, Andrea Modesti, Paolo Marchetti, Ester Alvino, Gian Carlo Antonini Cappellini
Publikováno v:
American journal of clinical pathology 142 (2014): 121–32. doi:10.1309/AJCPCX2D9YULBBLG
info:cnr-pdr/source/autori:Alvino, Ester; Passarelli, Francesca; Cannavo, Elda; Fortes, Cristina; Mastroeni, Simona; Caporali, Simona; Jiricny, Josef; Cappellini, Gian Carlo Antonini; Scoppola, Alessandro; Marchetti, Paolo; Modesti, Andrea; D'Atri, Stefania/titolo:High Expression of the Mismatch Repair Protein MSH6 Is Associated With Poor Patient Survival in Melanoma./doi:10.1309%2FAJCPCX2D9YULBBLG/rivista:American journal of clinical pathology/anno:2014/pagina_da:121/pagina_a:32/intervallo_pagine:121–32/volume:142
info:cnr-pdr/source/autori:Alvino, Ester; Passarelli, Francesca; Cannavo, Elda; Fortes, Cristina; Mastroeni, Simona; Caporali, Simona; Jiricny, Josef; Cappellini, Gian Carlo Antonini; Scoppola, Alessandro; Marchetti, Paolo; Modesti, Andrea; D'Atri, Stefania/titolo:High Expression of the Mismatch Repair Protein MSH6 Is Associated With Poor Patient Survival in Melanoma./doi:10.1309%2FAJCPCX2D9YULBBLG/rivista:American journal of clinical pathology/anno:2014/pagina_da:121/pagina_a:32/intervallo_pagine:121–32/volume:142
Objectives: The outcome of patients with primary melanoma (PM) cannot be completely explained based on currently adopted clinical-histopathologic criteria. In this study, we evaluated the potential prognostic value of mismatch repair protein expressi